HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J Am Dent Assoc, Vol 138, No 3, 355-361. © 2007 American Dental Association

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dowell, S. Articles by Robinson, M. Search for Related Content PubMed PubMed Citation Articles by Dowell, S. Articles by Robinson, M. Related Collections Implants

JADA Continuing Education

A pilot study

Background. The authors conducted a prospective cohort study to explore the relationship between implant success and glycemic control in patients with type 2 diabetes mellitus.

Methods. The authors used a two-phased enrollment, stratified by glycated hemoglobin (HbA1c) levels, to evaluate 50 implants in 35 subjects. The authors assessed nonsubmerged, nonrestored implants after placement, during healing and at abutment placement (35 newton centimeters) for restoration after four months. Outcomes assessed included implant success or failure, clinical complications and adverse events.

Results. The HbA1c levels of the subjects ranged from 4.5 to 13.8 percent. All 50 implants were integrated clinically. The authors identified three minor complications in three patients having HbA1c levels ranging from 7.4 to 8.3 percent. None of these complications affected the clinical management of the cases, and the authors did not identify any adverse events.

Conclusions. There was no evidence of diminished clinical success or significant early healing complications associated with implant therapy based on the glycemic control levels of subjects with type 2 diabetes mellitus.

Clinical Implications. These findings support the continued investigation of the effects of glycemic control on implant therapy toward the development of therapeutic guidelines that will optimize implant therapy in patients with diabetes.

Key Words: Implants; hyperglycemia; glycemic control; diabetes mellitus

Abbreviations: HbA1c: Glycated hemoglobin. • UTHSCSA: University of Texas Health Science Center San Antonio.

This article has been cited by other articles:

				T.W. Oates, S. Dowell, M. Robinson, and C.A. McMahan Glycemic Control and Implant Stabilization in Type 2 Diabetes Mellitus Journal of Dental Research, April 1, 2009; 88(4): 367 - 371. [Abstract] [Full Text] [PDF]